Dr. Schoen, Dr. Bonventre are new site miners at BWH

CIMIT welcomes two new site miners for Brigham and Women's Hospital, Frederick J. Schoen, MD, PhD, and Joseph V. Bonventre, MD, PhD.

Dr. Schoen is a professor of pathology and health sciences and technology at Harvard Medical School, and executive vice chairman of the Department of Pathology at BWH.

His areas of interest include cardiovascular pathology, cardiovascular biomaterials, prosthetic heart valve pathology and tissue engineering.

Dr. Schoen's research has included structure-function-pathology correlations in heart valve substitutions and other cardiovascular prosthese, cardiovascular tissue engineering and heart transplantation.

Dr. Schoen received a BSE (materials and metallurgical engineering) from the University of Michigan (1966), a PhD in materials science from Cornell University (1970) and an MD from the University of Miami School of Medicine (1974). Following a surgery internship, a residency in anatomic pathology and a fellowship in thoracic and cardiovascular pathology at the University of Florida, he joined BWH in 1980.

Dr. Bonventre is the Robert Ebert Professor of Medicine and Health Sciences and Technology at Harvard Medical School, and director of the Harvard-MIT division of Health Sciences. At BWH, he is director of the Renal Division.

His research interests include the mechanism of cellular and tissue injury and repair, particularly as applied to ischemic injury to the kidney.

A major focus of his laboratory studies is the phospholipase A2 (PLA2) and the role of this family of enzymes on acute injury, signal transduction and nuclear events including transcription.

Dr. Bonventre earned a BS in engineering physics from Cornell University (1970), an MD from Harvard Medical School (1976) and a PhD in biophysics from Harvard University (1979).